Angus Charles Russell's Insider Trades & SAST Disclosures
Angus Charles Russell's most recent trade in Structure Therapeutics Inc - ADR was a trade of 75,000 Share option (right to buy) done . Disclosure was reported to the exchange on Aug. 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Angus Charles Russell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc... | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 75,000 | 75,000 | - | - | Share option (right to buy) | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 23,458 | 23,458 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 15,000 | 51,506 (0%) | 0% | 0 | Common Stock | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 5,915 | 5,915 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,534 | 36,506 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Angus Charles Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Angus Charles Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 5,792 (0%) | 0% | - | Common Stock | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 10,756 | 10,756 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Purchase of securities on an exchange or from another person at price $ 15.74 per share. | 13 Dec 2021 | 6,400 | 26,913 (0%) | 0% | 15.7 | 100,741 | Common Stock |
| TherapeuticsMD Inc | Angus Charles Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 190,364 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Angus Charles Russell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 99,174 | 99,174 | - | - | Restricted Stock Units | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 7,551 | 7,551 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 4,013 | 20,513 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 96,864 | 96,864 | - | - | Restricted Stock Units | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Revance Therapeutics Inc | Angus Charles Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 6,000 | 16,500 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges